about
Tea consumption and prostate cancer: an updated meta-analysisA meta-analysis including dose-response relationship between night shift work and the risk of colorectal cancerDownregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway.MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathwayMeta-analysis of nonsteroidal anti-inflammatory drug intake and prostate cancer riskDiagnosis and treatment of community-associated methicillin-resistant Staphylococcus aureus prostatic abscess involving the seminal vesicle: A case report.MicroRNA-576-3p inhibits proliferation in bladder cancer cells by targeting cyclin D1.Systematic review and meta-analysis of the effect of alcohol intake on the risk of urolithiasis including dose-response relationship.MicroRNA-320c inhibits tumorous behaviors of bladder cancer by targeting Cyclin-dependent kinase 6Pesticide exposure and risk of bladder cancer: A meta-analysis.c-Met and CREB1 are involved in miR-433-mediated inhibition of the epithelial-mesenchymal transition in bladder cancer by regulating Akt/GSK-3β/Snail signaling.Is angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy protective against prostate cancer?Apigenin inhibits renal cell carcinoma cell proliferationA meta-analysis of tea consumption and the risk of bladder cancer.MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells.Apigenin inhibits migration and invasion via modulation of epithelial mesenchymal transition in prostate cancer.MicroRNA-193a-3p inhibits cell proliferation in prostate cancer by targeting cyclin D1.Updates in prostate cancer detections and treatments - Messages from 2017 EAU and AUA.Angiotensin-converting enzyme insertion/deletion polymorphism and the risk of prostate cancer in the Han population of China.
P50
Q21245600-DF4C32A7-DE26-44B0-8752-91233341BBA9Q26799794-84A9AB9D-EBA5-4892-91FD-516ED75D7902Q33694120-72FB37CA-1BC8-46A9-99CB-D4E48E477B89Q33733659-48442A2F-BFCC-41E9-8954-002934695A51Q34325928-E14D88A5-82C4-4BA5-9228-BA1586AFBD60Q35048748-F73E9592-69B7-48A9-9985-1F04793B6A10Q35093784-B2EE04E8-2894-433E-B9BA-73A234515558Q35208459-A3A72727-EC72-45B6-AE6A-6658F519E1F0Q35605883-3C4CE5C8-2F7F-4875-952A-1AE13AB730ECQ36111870-8C4399FB-2AC9-4B35-83E0-61488798D49CQ36847509-13B59062-1848-4BFE-B8D3-5DE2B4081FCFQ36916329-26711B53-0B27-49C5-9905-D8B0FF2DC2E6Q37746158-757E8067-6768-42D5-8838-FFF164B2BB1FQ38050975-79A1466E-BAB2-4352-B6B7-CDE309981892Q38838196-7216E243-9391-4192-A6F8-78DBC4EB2C87Q38944378-51EF02D7-CB66-4643-8B33-8DDD139920D3Q45849909-EE249858-5DAA-46D7-ABDD-7BFEE4B6F779Q52703028-1DFCEA5B-1A53-4FA7-BF33-939DCD9752D1Q54351805-D0824B3A-2DC9-4AD9-83C6-7423D30B4C1A
P50
description
researcher
@en
հետազոտող
@hy
name
Xiao Wang
@ast
Xiao Wang
@en
Xiao Wang
@es
Xiao Wang
@nl
Xiao Wang
@sl
type
label
Xiao Wang
@ast
Xiao Wang
@en
Xiao Wang
@es
Xiao Wang
@nl
Xiao Wang
@sl
prefLabel
Xiao Wang
@ast
Xiao Wang
@en
Xiao Wang
@es
Xiao Wang
@nl
Xiao Wang
@sl
P106
P214
44145970324632252480
P31
P496
0000-0002-8652-8820
P734
P735
P7859
viaf-44145970324632252480